Skip to content
Parakho

Gufic Biosciences Ltd

NSE GUFICBIOBSE 509079

Q1 FY27, unaudited

Revenue
₹260.82 Cr
Profit after tax
₹22.31 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations260.82+16.58%944.01
Other income0.46−50.55%2.66
Total income261.28+16.30%946.66
Employee benefit expense41.80+16.14%151.68
Finance costs9.32+0.92%36.61
Depreciation & amortisation7.71−0.17%30.83
Total expenses231.24+11.51%860.12
Profit before tax30.04+73.90%86.55
Tax expense7.73+83.80%22.34
Profit after tax22.31+70.71%64.21
Total comprehensive income22.39+71.29%64.71
Earnings per share
Earnings per share, basic₹2.22₹6.40
Earnings per share, diluted₹2.22₹6.40

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Gufic Biosciences reported Q4 FY26 revenue of around INR252 crores, its strongest quarter ever, with EBITDA margin expanding to 17.73% from 13.17% a year earlier and PAT more than doubling year-over-year. Full year FY26 revenue was INR940.50 crores versus INR820 crores in FY25, with EBITDA of INR152.9 crores and PAT of INR63.2 crores. Management attributed the quarterly improvement to the Indore facility reaching EBITDA breakeven at 30% capacity utilization, a working capital reset in the Critical Care cluster, and growth in the women's health and aesthetics platforms.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 40 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 21 Aug 2026.